Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 26;13(9):2966.
doi: 10.3390/nu13092966.

Effects of Supplementation with Folic Acid and Its Combinations with Other Nutrients on Cognitive Impairment and Alzheimer's Disease: A Narrative Review

Ana M Puga  1   2 , Mar Ruperto  1   2 , Mª de Lourdes Samaniego-Vaesken  1   2 , Ana Montero-Bravo  1   2 , Teresa Partearroyo  1   2 , Gregorio Varela-Moreiras  1   2
Affiliations
Review

Effects of Supplementation with Folic Acid and Its Combinations with Other Nutrients on Cognitive Impairment and Alzheimer's Disease: A Narrative Review

Ana M Puga et al. Nutrients. .

Abstract

Cognitive impairment and Alzheimer's Disease, among other cognitive dysfunctions, has been recognized as a major public health problem. Folic acid is a well-known essential nutrient whose deficiency has been linked to neurocognitive dysfunctions, owing to hyperhomocysteinemia, an independent risk factor for cardio- and cerebrovascular diseases, including cognitive impairment, Alzheimer's Disease, and vascular dementia. However, to date, there is certain controversy about the efficacy of vitamin supplementation in patients with these pathologies. Therefore, we have reviewed the available dietary intervention studies based on folic acid, either alone or in combination with different vitamins or nutrients into the progression of Alzheimer's Disease and Cognitive impairment, highlighting the cognition and biochemical markers employed for the evaluation of the disease progression. Undeniably, the compiled information supports the potential benefits of vitamin supplementation in these pathologies, especially relevant to the aging process and quality of life, although more research is urgently needed to confirm these positive findings.

Keywords: Alzheimer’s disease; cognitive function; folic acid; mild cognitive impairment; vascular dementia; vitamin supplementation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Alzheimer’s Disease International (ADI) The Global Impact of Dementia 2013–2050. [(accessed on 10 May 2021)]. Available online: https://www.alzint.org/resource/policy-brief-the-global-impact-of-dement...
    1. Schaller S., Mauskopf J., Kriza C., Wahlster P., Kolominsky-Rabas P.L. The main cost drivers in dementia: A systematic review. Int. J. Geriatr. Psychiatry. 2015;30:111–129. doi: 10.1002/gps.4198. - DOI - PubMed
    1. Petersen R.C., Stevens J., Ganguli M., Tangalos E.G., Cummings J., DeKosky S. Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1133–1142. doi: 10.1212/WNL.56.9.1133. - DOI - PubMed
    1. Jagger C., Matthews R., Lindesay J., Robinson T., Croft P., Brayne C. The effect of dementia trends and treatments on longevity and disability: A simulation model based on the MRC Cognitive Function and Ageing Study (MRC CFAS) Age Ageing. 2008;38:319–325. doi: 10.1093/ageing/afp016. - DOI - PubMed
    1. Daly E., Zaitchik D., Copeland M., Schmahmann J., Gunther J., Albert M. Predicting Conversion to Alzheimer Disease Using Standardized Clinical Information. Arch. Neurol. 2000;57:675–680. doi: 10.1001/archneur.57.5.675. - DOI - PubMed

MeSH terms